With China's DeepSeek AI model rocking the U.S. tech sector, some tech-heavy aggressive investors may wish to diversify into the Chinese market. Undoubtedly, Chinese internet stocks have been under ...

Madison Investments, an investment advisor, released its “Madison Mid Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, the fund (Class ...

With stock valuations climbing steadily over the past two years and artificial intelligence (AI) budgets of the big tech firms climbing by the year, it's only prudent to wonder if a bubble is in the ...

By Steven Scheer JERUSALEM (Reuters) -Check Point Software Technologies beat fourth-quarter profit expectations on Thursday, with revenue exceeding $2.5 billion in 2024, and forecast profit growth of ...

Stocks are ticking higher on Wall Street following a rush of profit reports from some of the country’s most influential companies. The S&P 500 rose 0.3% in early Thursday trading. The Dow Jones ...

WEXFORD, Pa. - Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP), known for its work in cell therapy for various diseases, has announced a significant rebranding to COEPTIS, signaling a strategic ...

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a look at where United Airlines Holdings, Inc. (NASDAQ:UAL) stands against ...

Tsai Capital, an investment management company, released its fourth quarter investor letter. A copy of the letter can be downloaded here. Tsai Capital celebrated 25 years track record in 2024. Tsai ...

In Thursday's premarket trading, the Nasdaq Composite is up about .53% as of 8:30 a.m. ET. The big story last night was earnings reports from many leading stocks in technology. Companies ...

Here are all the crucial things Tesla, Meta and Microsoft CEOs and CFOs said on their Wednesday evening quarterly conference calls as it relates to Capex and DeepSeek's potential impact on future ...

Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...

BOSTON - Elicio Therapeutics , Inc. (NASDAQ:ELTX), a clinical-stage biotech company focusing on cancer immunotherapies, has announced a registered direct offering priced at-the-market under Nasdaq ...